AZD7325 single ascending dose study in healthy male Japanese subjects - JSAD
Study identifier:D1140C00010
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Phase I,Single-center,Randomised,Double-blind,Placebo-controlled Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7325 in Healthy Male Japanese Subjects
Medical condition
Healthy Volunteer
Phase
Phase 1
Healthy volunteers
Yes
Study drug
AZD7325, Placebo
Sex
Male
Actual Enrollment
48
Study type
Interventional
Age
20 Years - 50 Years
Date
Study Start Date: 01 Oct 2008
Primary Completion Date: 01 Mar 2009
Study Completion Date: 01 Mar 2009
Study design
Allocation: Randomized
Endpoint Classification: Safety Study
Intervention Model: Parallel Assignment
Masking: Double Blind
Primary Purpose: Treatment
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Experimental: 1 | Drug: AZD7325 Capsule for oral, single dose |
| Placebo Comparator: 2 | Drug: Placebo Placebo capsule for oral, single dose |
Contacts
Investigators
Principal Investigator
Mark Yen
California Clinical Trials
